- Global Pharma News & Resources

Global Synthetic Biology Market Report: Data from 2019 to 2021, and CAGR Projections through 2026 -

DUBLIN--(BUSINESS WIRE)--The "Synthetic Biology: Global Markets" report has been added to's offering.

The study scope includes core synthetic biology products (e.g., oligonucleotides, synthetic genes, BioBrick parts, delivery plasmids, chassis organisms, synthetic cells, cell-based and cell-free production systems), enabling technologies (e.g., DNA sequencing, DNA synthesis, gene editing, bioinformatics, specialty media) and enabled technologies (e.g., healthcare, industrial chemicals, consumer products, food and beverage, agriculture) that are already commercialized or are forecast to be commercialized through 2026.

Key synthetic biology technologies and products are analyzed to determine present and future market status, as well as forecasted growth from 2021 to 2026. An in-depth discussion of strategic alliances, industry structures, competitive dynamics, patents and market-driving forces is also provided.

The publisher examines the synthetic biology industry by market segment, including DNA sequencing, DNA synthesis, gene editing, synthetic biology foundries and software; as well as the agriculture; consumer products, cosmetics and skin care, food and beverage, healthcare and industrial chemicals enable product sectors.

The role of key strategic alliances and acquisitions from 2018 to 2020 is discussed. Emerging markets, including synthetic genes, synthetic-biology-enabled drugs and vaccines, genome-edited crops and chassis organisms; as well as metabolically engineered factories for producing synthetic fuels and specialty chemicals, are analyzed, and more than 215 companies in these fields are highlighted.

The Report Includes

  • An up-to-date review and analysis of the global market for synthetic biology within the life science industry
  • Analyses of the global market trends, with data from 2019 to 2021, and projections of compound annual growth rates (CAGRs) through 2026
  • Evaluation and forecast the global synthetic biology market size, forecasted growth trends, and corresponding market share analysis by product type, end-user industry, and region
  • Highlights of the current and future market potential for synthetic biology products and technologies, and areas of focus to forecast this market into various segments and sub-segments
  • Description of core synthetic biology products, key enabling technologies, and identify commercial opportunities for product development and competitive strategies
  • In-depth assessment of the synthetic biology industry structure, competitors review, and intellectual property landscape
  • Information on synthetic biology industry M&A deals, development of commercially viable products and technologies, and other strategic alliances within the industry
  • Patent review and analysis of patents granted for synthetic biology technologies, liquid biopsy and sequencing, and gene-editing industry
  • Detailed profiles of about 185+ companies within synthetic biology industry. Major players include Agilent Technologies Inc., Eurofins Scientific, GenScript, Merck KGaA, Novozymes A/S, Thermo Fisher Scientific Inc., and Twist Bioscience


Key Topics Covered:


  • Synthetic Biology Technologies Covered in this Report
  • Value Chain Analysis
  • Synthetic Biology Overview
  • Development Stage of Synthetic Biology
  • Forces Driving the Growth of the Market for Synthetic Biology
  • Global Market for Synthetic Biology by End-User Industry
  • Product and Technology Life Cycles
  • Synthetic Biology Industry
  • Impact of COVID-19 on the Global Market for Synthetic Biology

Technology Background

Synthetic Biology Applications

Synthetic Biology Industry

Global Market for Synthetic Biology


Company Profiles

  • Abeona Therapeutics LLC
  • Agilent Technologies Inc.
  • Agrivida Inc.
  • Ajinomoto Co. Inc.
  • Algenuity
  • Ambrx Inc.
  • Antheia Inc.
  • Arcadia Biosciences Inc.
  • Arcturus Therapeutics Inc.
  • Ardra Bio Inc.
  • Arzeda Corp.
  • Astrazeneca plc
  • Atum
  • Avecia
  • Azitra Inc.
  • Basf AG
  • Bayer AG
  • Benchling
  • Biogen Inc.
  • Bioneer Corp.
  • Bolt Threads Inc.
  • Bristol-Myers Squibb Co.
  • Calysta Inc.
  • Calyxt Inc.
  • Cargill Inc.
  • Caszyme
  • Cellectis Sa
  • Chain Biotechnology Ltd.
  • Cibus Inc.
  • Codagenix Inc.
  • Codexis Inc.
  • Cronos Group
  • Danaher Corp.
  • Demuris Ltd.
  • Dowdupont Inc.
  • Edigene Inc.
  • Endless West
  • Enevolv Inc.
  • Epoch Life Science Inc.
  • Eurofins Scientific
  • Evolva Sa
  • Evonetix
  • Geltor Inc.
  • Genemed Synthesis Inc.
  • Genomatica
  • Genscript
  • Genus plc
  • Gevo Inc.
  • Gilead Sciences Inc.
  • Ginkgo Bioworks
  • GlaxoSmithKline plc
  • Global Bioenergies
  • Glycosyn LLC
  • Goodyear Tire & Rubber Co.
  • Helixworks Technologies Ltd.
  • Homology Medicines Inc.
  • Huvepharma
  • Illumina Inc.
  • Impossible Foods Inc.
  • Ingenza Ltd.
  • Inscripta Inc.
  • Labgenius Ltd.
  • Locus Biosciences
  • Lumen Bioscience
  • Lygos Inc.
  • Meissa Vaccines, Inc.
  • Merck
  • Microbyre, Inc.
  • Microsoft Corp.
  • Microsynbiotix
  • Milis Bio Ltd.
  • Modern Meadow
  • Modular Genetics Inc.
  • Molecular Assemblies Inc.
  • Morphosys AG
  • New England Biolabs
  • Novartis Pharma AG
  • Novome Biotechnologies Inc.
  • Novozymes A/S
  • Oragenics Inc.
  • Oxford Biomedica plc
  • Pairwise Plants Inc.
  • Pfizer Inc.
  • Poseida Therapeutics Inc.
  • Prokarium Holdings Ltd.
  • Promega Corp.
  • Sangamo Therapeutics Inc.
  • Sarepta Therapeutics Inc.
  • Scarab Genomics LLC
  • Senti Biosciences
  • Sherlock Biosciences
  • Sigma Aldrich Corp.
  • String Bio
  • Sugarlogix
  • Synlogic Therapeutics
  • Synthetic Biologics Inc.
  • Takara Bio
  • Tepha Inc.
  • Teselagen Biotechnology Inc.
  • Thermo Fisher Scientific Inc.
  • Tierra Biosciences
  • Toolgen
  • Transcriptic Inc.
  • Vedanta Biosciences
  • Vertex Pharmaceuticals Inc.
  • Viridos
  • Ziopharm Oncology, Inc.
  • Zymergen

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Editor Details

  • Company:
    • Businesswire
Last Updated: 10-Mar-2022